SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

1Life Healthcare Inc. – ‘8-K’ for 9/22/22

On:  Thursday, 9/22/22, at 8:47pm ET   ·   As of:  9/23/22   ·   For:  9/22/22   ·   Accession #:  1404123-22-70   ·   File #:  1-39203

Previous ‘8-K’:  ‘8-K/A’ on 9/7/22 for 9/2/22   ·   Next:  ‘8-K’ on / for 11/2/22   ·   Latest:  ‘8-K’ on / for 2/22/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 9/23/22  1Life Healthcare Inc.             8-K:5       9/22/22   10:177K

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     44K 
 5: R1          Cover                                               HTML     47K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- onem-20220922_htm                   XML     22K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 3: EX-101.LAB  XBRL Labels -- onem-20220922_lab                     XML     69K 
 4: EX-101.PRE  XBRL Presentations -- onem-20220922_pre              XML     34K 
 2: EX-101.SCH  XBRL Schema -- onem-20220922                         XSD     10K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    17K 
10: ZIP         XBRL Zipped Folder -- 0001404123-22-000070-xbrl      Zip     16K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:  C: 
  onem-20220922  
 i 0001404123 i FALSE00014041232022-09-222022-09-22

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
__________________________  
FORM  i 8-K 
__________________________ 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):  i September 22, 2022
__________________________  
 i 1LIFE HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
__________________________ 
 
 
 i Delaware i 001-39203 i 76-0707204
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
 i One Embarcadero Center,  i Suite 1900
 i San Francisco,  i CA  i 94111
 i (415)  i 814-0927
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former name or former address, if changed since last report)
__________________________  
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
 i 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading
Symbol(s)
 Name of each exchange
on which registered
 i Common Stock, $0.001 par value  i ONEM  i The Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company   i 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  



Item 5.07
Submission of Matters to a Vote of Security Holders.
On September 22, 2022, 1Life Healthcare, Inc. (“One Medical”) held a special meeting of its stockholders (the “Special Meeting”) to vote on the three proposals described in detail in One Medical’s definitive proxy statement filed with the U.S. Securities and Exchange Commission (the “SEC”) on August 24, 2022 and mailed to One Medical stockholders on or about such date (the “Proxy Statement”). As disclosed in the Proxy Statement, as of the close of business on August 22, 2022, the record date for the Special Meeting, there were 195,812,174 shares of One Medical’s common stock outstanding and entitled to vote at the Special Meeting. A total of 153,115,828 shares of One Medical’s common stock, representing approximately 78% of the shares outstanding and entitled to vote and constituting a quorum, were represented in person (virtually) or by valid proxies at the Special Meeting.
The final voting results for each of the proposals submitted to a vote of stockholders at the Special Meeting are as follows:
Proposal 1 – Adoption of the Merger Agreement
The stockholders of One Medical adopted the Agreement and Plan of Merger, dated July 20, 2022, (such agreement, as it may be amended, modified or supplemented from time to time, the “Merger Agreement”), by and among One Medical, a Delaware corporation, Amazon.com, Inc. (“Amazon”), a Delaware corporation, and Negroni Merger Sub, Inc. (“Merger Sub”), a Delaware corporation, pursuant to which Amazon will acquire One Medical via a merger of Merger Sub with and into One Medical, with One Medical continuing as the surviving corporation and an indirect wholly-owned subsidiary of Amazon. The voting results are set forth in the table immediately below:
For

AgainstAbstained
152,823,569

76,864
215,395
Proposal 2 - Non-binding Advisory Vote on Compensation of Named Executive Officers
The stockholders of One Medical approved, on an advisory (non-binding) basis, the compensation of One Medical’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. The voting results are set forth in the table immediately below:

For

AgainstAbstained
137,199,515

13,588,415
2,327,898
Proposal 3 – Adjournment of the Special Meeting, if necessary or appropriate

In connection with the Special Meeting, One Medical also solicited proxies with respect to any proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the proposal to adopt the Merger Agreement if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. Because there were sufficient votes represented at the time of the Special Meeting to approve the proposal to adopt the Merger Agreement, the proposal to approve one or more adjournments of the Special Meeting was moot and was not presented for approval by One Medical’s stockholders at the Special Meeting.

* * *




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 1LIFE HEALTHCARE, INC.
    
 By: /s/ Bjorn Thaler
Dated: September 22, 2022  Bjorn Thaler
   Chief Financial Officer



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed as of:9/23/22
Filed on / For Period end:9/22/22
8/24/22DEFM14A
8/22/22
7/20/228-K
 List all Filings 
Top
Filing Submission 0001404123-22-000070   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 7:04:51.1am ET